Public shortage context is available across 11 visible exact NDC pages for this generic family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Exact NDC product pages in this shortage family
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
| Drug Name | NDC 11 | Manufacturer | Shortage Context |
|---|
| Gentamicin Sulfate 80 mg / 100mL Injection 100 mL (Gentamicin Sulfate in Sodium Chloride) NDC 00338-0503-48 | 100 mL | Baxter Healthcare Corporation | 00338-0503-48 | Baxter Healthcare Corporation | Historical shortage context |
| Gentamicin Sulfate 100 mg / 100mL Injection 100 mL (Gentamicin Sulfate in Sodium Chloride) NDC 00338-0505-48 | 100 mL | Baxter Healthcare Corporation | 00338-0505-48 | Baxter Healthcare Corporation | Historical shortage context |
| Gentamicin Sulfate 60 mg / 50mL Injection 50 mL (Gentamicin Sulfate in Sodium Chloride) NDC 00338-0507-41 | 50 mL | Baxter Healthcare Corporation | 00338-0507-41 | Baxter Healthcare Corporation | Historical shortage context |
| Gentamicin Sulfate 60 mg / 50mL Injection 100 mL (Gentamicin Sulfate in Sodium Chloride) NDC 00338-0507-48 | 100 mL | Baxter Healthcare Corporation | 00338-0507-48 | Baxter Healthcare Corporation | Historical shortage context |
| Gentamicin Sulfate 80 mg / 50mL Injection 50 mL (Gentamicin Sulfate in Sodium Chloride) NDC 00338-0509-41 | 50 mL | Baxter Healthcare Corporation | 00338-0509-41 | Baxter Healthcare Corporation | Historical shortage context |
| Gentamicin Sulfate 100 mg / 50mL Injection 50 mL (Gentamicin Sulfate in Sodium Chloride) NDC 00338-0511-41 | 50 mL | Baxter Healthcare Corporation | 00338-0511-41 | Baxter Healthcare Corporation | Historical shortage context |
| Gentamicin Sulfate 40 mg / mL Injection 2 mLPRN Watchlist NDC 63323-0010-02 | 25 Vial | Fresenius Kabi USA, LLC | 63323-0010-02 | Fresenius Kabi USA, LLC | Historical shortage context |
| Gentamicin Sulfate 40 mg / mL Injection 20 mLPRN Watchlist NDC 63323-0010-20 | 25 Vial | Fresenius Kabi USA, LLC | 63323-0010-20 | Fresenius Kabi USA, LLC | Historical shortage context |
| Gentamicin Sulfate 40 mg / mL Injection 2 mLPRN Watchlist NDC 63323-0010-94 | 25 Vial, Multi-Dose | Fresenius Kabi USA, LLC | 63323-0010-94 | Fresenius Kabi USA, LLC | Historical shortage context |
| Gentamicin Sulfate 40 mg / mL Injection 20 mLPRN Watchlist NDC 63323-0010-95 | 25 Vial, Multi-Dose | Fresenius Kabi USA, LLC | 63323-0010-95 | Fresenius Kabi USA, LLC | Historical shortage context |
| Gentamicin Sulfate 40 mg / mL Injection 2 mLPRN Watchlist NDC 00409-1207-03 | 25 Vial, Single-Dose | Hospira, Inc. | 00409-1207-03 | Hospira, Inc. | Historical shortage context |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.